Rituximab-induced acute severe thrombocytopenia: a case series in patients with mantle cell lymphoma

Clin Lymphoma Myeloma Leuk. 2013 Oct;13(5):602-5. doi: 10.1016/j.clml.2013.04.013. Epub 2013 Jul 17.

Authors

Santhosh K Sadashiv¹, Rohit Rao, Salman Fazal, John Lister

Affiliation

¹ Division of Hematology Oncology, Western Pennsylvania Cancer Institute, 4800 Friendship Ave, Suite 2303NT, Pittsburgh, PA 15224-1791. Electronic address: ssadashi@wpahs.org.

PMID: 23870855
DOI: 10.1016/j.clml.2013.04.013

No abstract available

Keywords: Mantle cell lymphoma; Rituximab; Thrombocytopenia.

Publication types

Case Reports

MeSH terms

Acute Disease
Aged
Antibodies, Monoclonal, Murine-Derived / adverse effects*
Antibodies, Monoclonal, Murine-Derived / therapeutic use
Antineoplastic Agents / adverse effects*
Antineoplastic Agents / therapeutic use
Female
Humans
Lymphoma, Mantle-Cell / complications
Lymphoma, Mantle-Cell / drug therapy
Male
Middle Aged
Platelet Count
Rituximab
Thrombocytopenia / chemically induced*
Thrombocytopenia / diagnosis

Substances

Antibodies, Monoclonal, Murine-Derived
Antineoplastic Agents
Rituximab